{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:13:53Z","timestamp":1695208433753},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.rbmo.2019.08.006","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T05:53:55Z","timestamp":1566798835000},"page":"877","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-tailored luteal phase support with progesterone may avoid unnecessary oocyte donation failures"],"prefix":"10.1016","volume":"39","author":[{"given":"Jan","family":"Tesarik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Mendoza-Tesarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.08.006_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2019.05.001","article-title":"Weekly intramuscular progesterone for luteal phase support in women receiving oocyte donation is associated with a decreased miscarriage rate","author":"Delcour","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2019.08.006_bib0002","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41598-017-18643-w","article-title":"The high concentration of progesterone is harmful for endometrial receptivity and decidualization","volume":"8","author":"Liang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rbmo.2019.08.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2019.03.215","article-title":"GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study","author":"Mendoza-Tesarik","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2019.08.006_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.33590\/emj\/10313812","article-title":"Customised oocyte donation enhancement and new findings regarding the role of growth hormone","volume":"3","author":"Tesarik","year":"2018","journal-title":"Eur. Med. J."},{"key":"10.1016\/j.rbmo.2019.08.006_bib0005","first-page":"216","article-title":"The neglected luteal phase after natural conception: rescue by early progesterone supplementation","volume":"2","author":"Tesarik","year":"2019","journal-title":"Curr. Op. Gynecol. Obstet."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319307060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T12:21:12Z","timestamp":1695126072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319307060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1472648319307060"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.08.006","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-tailored luteal phase support with progesterone may avoid unnecessary oocyte donation failures","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}